Anja Zupan Mežnar on LinkedIn: "Precision medicine - identifying the ...

Responsive image
source
American Journal of Hematology | Blood Research Journal | Wiley Online ...

American Journal of Hematology | Blood Research Journal | Wiley Online ...
Study design of the EWAS of lung function in Mexican Americans and ...

Study design of the EWAS of lung function in Mexican Americans and ...
SELECT Trial: Semaglutide and CV outcomes - Visualmed

SELECT Trial: Semaglutide and CV outcomes - Visualmed
Hernandez-Ilizaliturri Lab Publications | Roswell Park Comprehensive ...

Hernandez-Ilizaliturri Lab Publications | Roswell Park Comprehensive ...
Full article: HERTHENA-Lung01: A Phase II Study of Patritumab ...

Full article: HERTHENA-Lung01: A Phase II Study of Patritumab ...
Publication Digest | CDK 4/6 Inhibitors | Medthority.com

Publication Digest | CDK 4/6 Inhibitors | Medthority.com
Tranexamic acid evidence and controversies: An illustrated review ...

Tranexamic acid evidence and controversies: An illustrated review ...
JACC: Cardiovascular Imaging

JACC: Cardiovascular Imaging
GP Consultation Aid

GP Consultation Aid
Series on using GRADE in nutrition systematic reviews | Cochrane Nutrition

Series on using GRADE in nutrition systematic reviews | Cochrane Nutrition
Pneumonia 2 - S/N - Respiratory Pneumonia II Patient care Discharge ...

Pneumonia 2 - S/N - Respiratory Pneumonia II Patient care Discharge ...
(PDF) Quality indicators for palliative care services (Q-PAC): mixed ...

(PDF) Quality indicators for palliative care services (Q-PAC): mixed ...
Evolving Standards in Biomarker Testing, Scoring, and Results ...

Evolving Standards in Biomarker Testing, Scoring, and Results ...
Inappropriate Antibiotic Prescribing Leads to Increased Costs ...

Inappropriate Antibiotic Prescribing Leads to Increased Costs ...
Homelessness in Scotland: 2020 to 2021 - gov.scot

Homelessness in Scotland: 2020 to 2021 - gov.scot
MICHELLE Trial Summary: Rivaroxaban for Thromboprophylaxis in Covid-19 ...

MICHELLE Trial Summary: Rivaroxaban for Thromboprophylaxis in Covid-19 ...
Obexelimab in Systemic Lupus Erythematosus With Exploration of Response ...

Obexelimab in Systemic Lupus Erythematosus With Exploration of Response ...
View symposium posters | Centre for Teaching and Learning

View symposium posters | Centre for Teaching and Learning
Optimizing frontline immunotherapy for advanced NSCLC - touchONCOLOGY

Optimizing frontline immunotherapy for advanced NSCLC - touchONCOLOGY
Water Management Program Performance Indicators

Water Management Program Performance Indicators
#VisualAbstract Progression-Free Survival (PFS) was significantly ...

#VisualAbstract Progression-Free Survival (PFS) was significantly ...
Children with familial hypercholesterolemia are diagnosed late and ...

Children with familial hypercholesterolemia are diagnosed late and ...
Coronary Vasomotor Dysfunction Is Associated With Cardiovascular Events ...

Coronary Vasomotor Dysfunction Is Associated With Cardiovascular Events ...
Lassa fever | The BMJ

Lassa fever | The BMJ
#VisualAbstract: Male sex and older age are independently associated ...

#VisualAbstract: Male sex and older age are independently associated ...
ARDS: Deep Dive into the Evidence EMRA

ARDS: Deep Dive into the Evidence EMRA
#VisualAbstract: Optical Coherence Tomography–Guided versus Angiography ...

#VisualAbstract: Optical Coherence Tomography–Guided versus Angiography ...
Essential aspects of the follow‐up after acute pulmonary embolism: An ...

Essential aspects of the follow‐up after acute pulmonary embolism: An ...
Spread the Word about REPRIEVE! - REPRIEVE Trial

Spread the Word about REPRIEVE! - REPRIEVE Trial
First-in-human randomized study of RNAi therapeutic RG6346 for chronic ...

First-in-human randomized study of RNAi therapeutic RG6346 for chronic ...
Viscoelastic testing: an illustrated review of technology and clinical ...

Viscoelastic testing: an illustrated review of technology and clinical ...
2022 update to the position statement by Primary Care Diabetes Europe ...

2022 update to the position statement by Primary Care Diabetes Europe ...